Head-to-head · Cost-Efficiency Index
Defy Medical vs EmbraceRX
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Defy Medical
Cost-first shoppers who want existing or prospective TRT/men's-health patients wanting to add GLP-1 to an established hormone-optimization relationship -- not the first stop for a shopper solely comparing dedicated GLP-1 weight-loss pricing.
Visit Defy MedicalEmbraceRX
Cost-first shoppers who want compounded GLP-1 plus a deep peptide and longevity menu, prescribed online.
Visit EmbraceRXThe verdict
Defy Medical and EmbraceRX tie on the Cost-Efficiency Index at 43/100, so neither wins outright on the numbers. For most shoppers we'd start with Defy Medical (ranked #492, a hair above #493) — Cost-first shoppers who want existing or prospective TRT/men's-health patients wanting to add GLP-1 to an established hormone-optimization relationship -- not the first stop for a shopper solely comparing dedicated GLP-1 weight-loss pricing. But EmbraceRX is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Defy Medical.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Defy Medical | EmbraceRX |
|---|---|---|
| Cost-Efficiency Index | 43/100 | 43/100 |
| Semaglutide / mo | Not disclosed | Not disclosed |
| Tirzepatide / mo | Not disclosed | Not disclosed |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | — | — |
| Coverage | Coverage not published | Coverage not published |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #492 | #493 |
Defy Medical
43/100Where the value is
- Named, credentialed Medical Director (Dr. Justin Saya)
- Large third-party review base (3,999 Trustpilot reviews, 5-star average)
- Offers both semaglutide and tirzepatide alongside broader men's-health services
The tradeoffs
- GLP-1 is clearly a secondary offering bolted onto a primarily TRT/hormone-optimization practice, not its core focus
- Zero pricing disclosed anywhere on the public site -- fully gated behind quiz/consultation
EmbraceRX
43/100Where the value is
- Broad compounded GLP-1 menu — semaglutide (+B12), tirzepatide, oral semaglutide/tirzepatide capsules, plus Lipo-B
- Large peptide/longevity catalog (BPC-157, GHK-Cu, NAD+, MOTS-C) across injectable, oral, topical, and nasal formats
- Clinician-guided, compounded at FDA-registered pharmacies; partners with a licensed physician network (Samaritan MD)
The tradeoffs
- Pricing not shown upfront — revealed only at checkout after a dose selection
- Offers investigational/research compounds (e.g., retatrutide, AOD-9604) that are not FDA-approved
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.